Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Schoenberg Mark Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 30,000 restricted stock units @ $0
02/02/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 248 shares @ $10.12, valued at $2.5k
Sold 991 shares @ $10.12, valued at $10k
Sold 661 shares @ $10.12, valued at $6.7k
Exercised 500 restricted stock units @ $0
Exercised 2,000 restricted stock units @ $0
Exercised 1,333 restricted stock units @ $0
Granted 10,000 restricted stock units @ $0
Granted 30,000 options to buy @ $10.39, valued at $311.7k
01/23/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 122,677 options to buy @ $5, valued at $613.4k
08/25/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 259 shares @ $7.81, valued at $2k
Exercised 500 restricted stock units @ $0
05/03/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 254 shares @ $6.62, valued at $1.7k
Exercised 500 restricted stock units @ $0
02/02/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 275 shares @ $7.58, valued at $2.1k
Sold 1,099 shares @ $7.58, valued at $8.3k
Exercised 500 restricted stock units @ $0
Granted 12,064 options to buy @ $7.72, valued at $93.1k
Granted 4,000 restricted stock units @ $0
Exercised 2,000 restricted stock units @ $0
01/28/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 111 shares @ $8.09, valued at $898
Exercised 209 restricted stock units @ $0
11/19/2021 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Bought 160 shares @ $13.1, valued at $2.1k
11/02/2021 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 258 shares @ $17.16, valued at $4.4k
Exercised 500 restricted stock units @ $0
10/28/2021 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 107 shares @ $16.32, valued at $1.7k
Exercised 208 restricted stock units @ $0
08/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 1,076 shares @ $22.07, valued at $23.7k
Exercised 2,000 restricted stock units @ $0
Granted 21,000 options to buy @ $22.07, valued at $463.5k
Granted 6,000 restricted stock units @ $0
01/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 662 shares @ $19.85, valued at $13.1k
Exercised 1,042 restricted stock units @ $0
10/28/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 101 shares @ $20.9461, valued at $2.1k
Exercised 208 restricted stock units @ $0
09/08/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 348 shares @ $20.2, valued at $7k
Exercised 1,041 restricted stock units @ $0
07/28/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 70 shares @ $23.51, valued at $1.6k
Exercised 209 restricted stock units @ $0
06/05/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 349 shares @ $27.5128, valued at $9.6k
Exercised 1,042 restricted stock units @ $0
04/28/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 70 shares @ $24.35, valued at $1.7k
Exercised 208 restricted stock units @ $0
03/04/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Paid exercise price by delivering 345 shares @ $29.5, valued at $10.2k
Exercised 1,042 restricted stock units @ $0
02/13/2020 3/A Schoenberg Mark (Chief Medical Officer) has filed a Form 3/A on UroGen Pharma Ltd.
02/04/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 15,000 options to buy @ $29.41, valued at $441.2k
Granted 6,000 restricted stock units @ $0
01/28/2020 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 322 shares @ $29.15, valued at $9.4k
Exercised 833 options to buy @ $0
12/05/2019 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Paid exercise price by delivering 343 shares @ $31.69, valued at $10.9k
Exercised 1,042 options to buy @ $0
11/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2019 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 343 shares @ $33.92, valued at $11.6k
Exercised 1,041 options to buy @ $0
06/06/2019 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Paid exercise price by delivering 343 shares @ $35.05, valued at $12k
Exercised 1,042 options to buy @ $0
03/22/2019 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Bought 272 shares @ $37.009, valued at $10.1k
03/07/2019 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 1,991 shares @ $37.3, valued at $74.3k
Exercised 1,042 options to buy @ $0
03/07/2019 3/A Schoenberg Mark (Chief Medical Officer) has filed a Form 3/A on UroGen Pharma Ltd.
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy